137 related articles for article (PubMed ID: 38728472)
21. Gut microbiota and autism spectrum disorders: where do we stand?
Zyoud SH; Shakhshir M; Abushanab AS; Koni A; Shahwan M; Jairoun AA; Abu Taha A; Al-Jabi SW
Gut Pathog; 2023 Oct; 15(1):50. PubMed ID: 37880713
[TBL] [Abstract][Full Text] [Related]
22. Global trends in research related to the links between microbiota and antibiotics: a visualization study.
Zyoud SH; Shakhshir M; Abushanab AS; Koni A; Taha AA; Abushamma F; Sabateen A; Al-Jabi SW
Sci Rep; 2023 Apr; 13(1):6890. PubMed ID: 37106254
[TBL] [Abstract][Full Text] [Related]
23. Type 2 Diabetes and the Microbiome.
Barlow GM; Mathur R
J Endocr Soc; 2022 Dec; 7(2):bvac184. PubMed ID: 36578879
[TBL] [Abstract][Full Text] [Related]
24. Microbiota Modulation in Patients with Metabolic Syndrome.
Araujo R; Borges-Canha M; Pimentel-Nunes P
Nutrients; 2022 Oct; 14(21):. PubMed ID: 36364752
[TBL] [Abstract][Full Text] [Related]
25. Gut Microbiota Modulation as a Novel Therapeutic Strategy in Cardiometabolic Diseases.
Mutalub YB; Abdulwahab M; Mohammed A; Yahkub AM; Al-Mhanna SB; Yusof W; Tang SP; Rasool AHG; Mokhtar SS
Foods; 2022 Aug; 11(17):. PubMed ID: 36076760
[TBL] [Abstract][Full Text] [Related]
26. Immunomodulatory effects of microbiota-derived metabolites at the crossroad of neurodegenerative diseases and viral infection: network-based bioinformatics insights.
Onisiforou A; Spyrou GM
Front Immunol; 2022; 13():843128. PubMed ID: 35928817
[TBL] [Abstract][Full Text] [Related]
27. Psychobiotics: the Influence of Gut Microbiota on the Gut-Brain Axis in Neurological Disorders.
Oroojzadeh P; Bostanabad SY; Lotfi H
J Mol Neurosci; 2022 Sep; 72(9):1952-1964. PubMed ID: 35849305
[TBL] [Abstract][Full Text] [Related]
28. Role of Microbiota in Viral Infections and Pathological Progression.
Mizutani T; Ishizaka A; Koga M; Tsutsumi T; Yotsuyanagi H
Viruses; 2022 May; 14(5):. PubMed ID: 35632692
[TBL] [Abstract][Full Text] [Related]
29. Microbiota in health and diseases.
Hou K; Wu ZX; Chen XY; Wang JQ; Zhang D; Xiao C; Zhu D; Koya JB; Wei L; Li J; Chen ZS
Signal Transduct Target Ther; 2022 Apr; 7(1):135. PubMed ID: 35461318
[TBL] [Abstract][Full Text] [Related]
30. Gut microbiota modulation: a tool for the management of colorectal cancer.
Wang Y; Li H
J Transl Med; 2022 Apr; 20(1):178. PubMed ID: 35449107
[TBL] [Abstract][Full Text] [Related]
31. Impact of antibiotics on the human microbiome and consequences for host health.
Patangia DV; Anthony Ryan C; Dempsey E; Paul Ross R; Stanton C
Microbiologyopen; 2022 Feb; 11(1):e1260. PubMed ID: 35212478
[TBL] [Abstract][Full Text] [Related]
32. Gut microbiota modulation as a possible mediating mechanism for fasting-induced alleviation of metabolic complications: a systematic review.
Angoorani P; Ejtahed HS; Hasani-Ranjbar S; Siadat SD; Soroush AR; Larijani B
Nutr Metab (Lond); 2021 Dec; 18(1):105. PubMed ID: 34906176
[TBL] [Abstract][Full Text] [Related]
33. Gut Microbiota Modulation as a Potential Target for the Treatment of Lung Infections.
Cruz CS; Ricci MF; Vieira AT
Front Pharmacol; 2021; 12():724033. PubMed ID: 34557097
[TBL] [Abstract][Full Text] [Related]
34. Functional gastrointestinal disorders: History taking skills in practice.
Daly M; Zarate-Lopez N
Clin Med (Lond); 2021 Sep; 21(5):e480-e486. PubMed ID: 34385299
[TBL] [Abstract][Full Text] [Related]
35. Regulation, risk and safety of Faecal Microbiota Transplant.
Merrick B; Allen L; Masirah M Zain N; Forbes B; Shawcross DL; Goldenberg SD
Infect Prev Pract; 2020 Sep; 2(3):100069. PubMed ID: 34316559
[TBL] [Abstract][Full Text] [Related]
36. Modulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes.
Huda MN; Kim M; Bennett BJ
Front Endocrinol (Lausanne); 2021; 12():632335. PubMed ID: 33897618
[TBL] [Abstract][Full Text] [Related]
37. The Contribution of Gut Microbiota-Brain Axis in the Development of Brain Disorders.
Maiuolo J; Gliozzi M; Musolino V; Carresi C; Scarano F; Nucera S; Scicchitano M; Oppedisano F; Bosco F; Ruga S; Zito MC; Macri R; Palma E; Muscoli C; Mollace V
Front Neurosci; 2021; 15():616883. PubMed ID: 33833660
[TBL] [Abstract][Full Text] [Related]
38. Influence of immunomodulatory drugs on the gut microbiota.
Cohen I; Ruff WE; Longbrake EE
Transl Res; 2021 Jul; 233():144-161. PubMed ID: 33515779
[TBL] [Abstract][Full Text] [Related]
39. Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes.
Front Immunol; ; . PubMed ID: 33178196
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
